tradingkey.logo

Turn Therapeutics Ord Shs

TTRX
4.860USD
+0.130+2.75%
收盘 01/23, 16:00美东报价延迟15分钟
136.19M总市值
亏损市盈率 TTM

Turn Therapeutics Ord Shs

4.860
+0.130+2.75%

关于 公司

Turn Therapeutics Ord Shs简介

公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -

Turn Therapeutics Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Arthur F. Golden
Mr. Arthur F. Golden
Independent Director Nominee
Independent Director Nominee
60.60K
+30400.00%
Mr. Zuraiz Chaudhary
Mr. Zuraiz Chaudhary
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
12.50K
+2500.00%
Dr. Kent Kester
Dr. Kent Kester
Independent Director Nominee
Independent Director Nominee
10.00K
+10000.00%
Mr. Bradley Burnam
Mr. Bradley Burnam
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Andrew Gengos
Mr. Andrew Gengos
Independent Director
Independent Director
--
--
Dr. Neilesh Shailesh (Neil) Ghodadra
Dr. Neilesh Shailesh (Neil) Ghodadra
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Arthur F. Golden
Mr. Arthur F. Golden
Independent Director Nominee
Independent Director Nominee
60.60K
+30400.00%
Mr. Zuraiz Chaudhary
Mr. Zuraiz Chaudhary
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
12.50K
+2500.00%
Dr. Kent Kester
Dr. Kent Kester
Independent Director Nominee
Independent Director Nominee
10.00K
+10000.00%
Mr. Bradley Burnam
Mr. Bradley Burnam
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Andrew Gengos
Mr. Andrew Gengos
Independent Director
Independent Director
--
--
Dr. Neilesh Shailesh (Neil) Ghodadra
Dr. Neilesh Shailesh (Neil) Ghodadra
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 1月18日 周日
更新时间: 1月18日 周日
持股股东
股东类型
持股股东
持股股东
占比
BEB Holdings LLC
54.39%
YJA Investment Family LP
4.87%
ANC Carlson Family LP
4.87%
Golden (Arthur F)
0.21%
Clear Street LLC
0.18%
其他
35.48%
持股股东
持股股东
占比
BEB Holdings LLC
54.39%
YJA Investment Family LP
4.87%
ANC Carlson Family LP
4.87%
Golden (Arthur F)
0.21%
Clear Street LLC
0.18%
其他
35.48%
股东类型
持股股东
占比
Corporation
64.13%
Individual Investor
0.28%
Research Firm
0.18%
Investment Advisor
0.18%
Investment Advisor/Hedge Fund
0.06%
其他
35.17%

机构持股

更新时间: 1月21日 周三
更新时间: 1月21日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
2
71.61K
0.06%
--
2025Q4
2
71.61K
0.24%
+54.47K

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BEB Holdings LLC
16.02M
54.39%
+16.02M
--
Oct 08, 2025
YJA Investment Family LP
1.43M
4.87%
+1.43M
--
Oct 08, 2025
ANC Carlson Family LP
1.43M
4.87%
+1.43M
--
Oct 08, 2025
Golden (Arthur F)
60.60K
0.21%
+30.40K
+100.66%
Nov 24, 2025
Clear Street LLC
54.47K
0.18%
+54.47K
--
Oct 08, 2025
Geode Capital Management, L.L.C.
17.14K
0.06%
--
--
Nov 30, 2025
Chaudhary (Zuraiz)
12.50K
0.04%
+2.50K
+25.00%
Dec 12, 2025
Kester (Kent Edward)
10.00K
0.03%
+10.00K
--
Oct 08, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI